Antibody Responses Against Emerging SARS-CoV-2 Omicron Lineages After the Fourth Dose of mRNA Vaccine in Kidney Transplant Recipients

Transplantation. 2023 Jun 1;107(6):e178-e181. doi: 10.1097/TP.0000000000004582. Epub 2023 May 23.

Authors

Ayman Al Jurdi^{1

2}, Rodrigo B Gassen¹, Thiago J Borges¹, Isadora T Lape¹, Leela Morena¹, Frank Hullekes¹, Orhan Efe^{1

2}, Camille N Kotton³, Leonardo V Riella^{1

2}

Affiliations

¹ Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA.
² Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
³ Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

No abstract available

MeSH terms

Antibodies, Neutralizing
Antibodies, Viral
Antibody Formation
COVID-19*
Humans
Kidney Transplantation*
SARS-CoV-2
Transplant Recipients
mRNA Vaccines

Substances

Antibodies, Viral
Antibodies, Neutralizing